Halozyme Therapeutics shares owned by Skandinaviska Enskilda Banken AB
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Skandinaviska Enskilda Banken AB
from 13F filings
Historical chart of Skandinaviska Enskilda Banken AB investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by Skandinaviska Enskilda Banken AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.7M | 37k | 73.34 |
| 2025-06-30 | $2.7M | 51k | 52.00 |
| 2025-03-31 | $4.3M | 68k | 63.78 |
| 2024-12-31 | $1.5M | 32k | 48.00 |
| 2024-09-30 | $2.7M | 48k | 57.21 |
| 2023-06-30 | $400k | 11k | 36.08 |
| 2023-03-31 | $614k | 16k | 38.17 |
| 2022-12-31 | $659k | 12k | 56.90 |
| 2022-09-30 | $1.2M | 31k | 39.55 |
| 2022-06-30 | $2.3M | 53k | 44.01 |
| 2022-03-31 | $2.1M | 53k | 39.89 |
| 2021-12-31 | $13M | 323k | 40.32 |
| 2021-09-30 | $14M | 344k | 40.68 |
| 2021-06-30 | $8.9M | 196k | 45.41 |
| 2021-03-31 | $8.2M | 196k | 41.69 |
| 2020-12-31 | $2.6M | 61k | 42.72 |
| 2020-09-30 | $2.1M | 81k | 26.28 |
| 2020-06-30 | $866k | 32k | 26.81 |
More positions owned by Skandinaviska Enskilda Banken AB
View all positions for Skandinaviska Enskilda Banken AB